🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/03/2000 | 60,89 | 61,96 | 59,28 | 59,28 | -3,02% | 4,41% | 5.934.405 |
| 30/03/2000 | 61,07 | 62,92 | 60,89 | 61,13 | +0,10% | 3,32% | 6.606.173 |
| 29/03/2000 | 60,05 | 62,02 | 59,64 | 61,07 | +3,96% | 3,97% | 7.385.466 |
| 28/03/2000 | 57,01 | 59,64 | 57,01 | 58,74 | +0,72% | 4,60% | 7.956.416 |
| 27/03/2000 | 58,09 | 58,74 | 57,13 | 58,33 | -1,01% | 2,77% | 5.846.268 |
| 24/03/2000 | 60,00 | 60,11 | 57,61 | 58,92 | -1,79% | 4,18% | 7.016.989 |
| 23/03/2000 | 60,65 | 61,78 | 59,70 | 60,00 | -2,42% | 3,44% | 5.059.849 |
| 22/03/2000 | 60,17 | 61,96 | 60,11 | 61,49 | +0,78% | 3,07% | 5.527.362 |
| 21/03/2000 | 58,80 | 61,07 | 58,74 | 61,01 | +3,75% | 3,96% | 5.390.283 |
| 20/03/2000 | 58,80 | 59,34 | 57,55 | 58,80 | -1,79% | 3,04% | 6.412.398 |
| 17/03/2000 | 61,96 | 62,02 | 59,82 | 59,88 | -3,46% | 3,56% | 8.924.139 |
| 16/03/2000 | 57,67 | 62,68 | 57,43 | 62,02 | +8,67% | 9,10% | 15.846.598 |
| 15/03/2000 | 53,67 | 57,25 | 53,49 | 57,07 | +5,86% | 7,00% | 9.626.509 |
| 14/03/2000 | 53,32 | 54,15 | 52,84 | 53,91 | -0,88% | 2,46% | 7.484.082 |
| 13/03/2000 | 53,79 | 55,05 | 53,55 | 54,39 | -4,30% | 2,77% | 9.302.991 |
| 10/03/2000 | 58,92 | 59,04 | 56,30 | 56,83 | -2,56% | 4,66% | 8.712.967 |
| 09/03/2000 | 55,82 | 58,80 | 55,05 | 58,33 | +7,59% | 6,73% | 12.869.650 |
| 08/03/2000 | 51,47 | 54,81 | 51,47 | 54,21 | +5,33% | 6,49% | 12.569.712 |
| 07/03/2000 | 53,44 | 53,44 | 49,62 | 51,47 | -4,54% | 7,14% | 13.544.142 |
| 06/03/2000 | 54,81 | 55,11 | 53,67 | 53,91 | -1,74% | 2,61% | 9.103.138 |
| 03/03/2000 | 57,31 | 57,37 | 54,45 | 54,87 | -2,95% | 5,10% | 10.706.892 |
| 02/03/2000 | 57,31 | 57,97 | 56,54 | 56,54 | -1,25% | 2,50% | 6.167.061 |
| 01/03/2000 | 58,68 | 58,92 | 57,01 | 57,25 | -2,54% | 3,25% | 7.289.574 |
| 29/02/2000 | 59,58 | 60,23 | 58,56 | 58,74 | +0,00% | 2,80% | 8.243.778 |
| 28/02/2000 | 57,43 | 59,10 | 57,25 | 58,74 | +2,28% | 3,22% | 8.895.634 |
| 25/02/2000 | 58,27 | 58,68 | 56,48 | 57,43 | -2,92% | 3,79% | 8.070.962 |
| 24/02/2000 | 60,41 | 60,41 | 57,91 | 59,16 | -1,78% | 4,15% | 9.502.006 |
| 23/02/2000 | 62,98 | 62,98 | 60,23 | 60,23 | -3,63% | 4,36% | 8.099.468 |
| 22/02/2000 | 59,64 | 62,50 | 58,98 | 62,50 | +5,65% | 5,90% | 9.640.971 |
| 18/02/2000 | 60,53 | 61,43 | 58,74 | 59,16 | -1,98% | 4,43% | 6.934.721 |